Veracyte, Inc. (VCYT)
NASDAQ: VCYT · IEX Real-Time Price · USD
20.33
+0.20 (0.99%)
May 2, 2024, 2:02 PM EDT - Market open

Veracyte Revenue

In the year 2023, Veracyte had annual revenue of $361.05M with 21.76% growth. Revenue in the quarter ending December 31, 2023 was $98.20M with 22.29% year-over-year growth.

Revenue (ttm)
$361.05M
Revenue Growth
+21.76%
P/S Ratio
4.19
Revenue / Employee
$443,007
Employees
815
Market Cap
1.53B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023361.05M64.52M21.76%
Dec 31, 2022296.54M77.02M35.09%
Dec 31, 2021219.51M102.03M86.85%
Dec 31, 2020117.48M-2.89M-2.40%
Dec 31, 2019120.37M28.36M30.82%
Dec 31, 201892.01M20.06M27.87%
Dec 31, 201771.95M6.87M10.55%
Dec 31, 201665.09M15.58M31.48%
Dec 31, 201549.50M11.31M29.62%
Dec 31, 201438.19M16.31M74.51%
Dec 31, 201321.88M10.26M88.20%
Dec 31, 201211.63M8.98M339.62%
Dec 31, 20112.65M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
National HealthCare 1.14B
InMode 492.05M
Dynavax Technologies 232.28M
LeMaitre Vascular 193.48M
Ardelyx 124.46M
Protagonist Therapeutics 60.00M
Revenue Rankings